1. Home
  2. RCUS vs PLAB Comparison

RCUS vs PLAB Comparison

Compare RCUS & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • PLAB
  • Stock Information
  • Founded
  • RCUS 2015
  • PLAB 1969
  • Country
  • RCUS United States
  • PLAB United States
  • Employees
  • RCUS N/A
  • PLAB N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • PLAB Semiconductors
  • Sector
  • RCUS Health Care
  • PLAB Technology
  • Exchange
  • RCUS Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • RCUS 1.2B
  • PLAB 1.2B
  • IPO Year
  • RCUS 2018
  • PLAB 1987
  • Fundamental
  • Price
  • RCUS $13.90
  • PLAB $23.56
  • Analyst Decision
  • RCUS Buy
  • PLAB Strong Buy
  • Analyst Count
  • RCUS 7
  • PLAB 2
  • Target Price
  • RCUS $22.00
  • PLAB $31.00
  • AVG Volume (30 Days)
  • RCUS 937.9K
  • PLAB 919.0K
  • Earning Date
  • RCUS 11-05-2025
  • PLAB 08-27-2025
  • Dividend Yield
  • RCUS N/A
  • PLAB N/A
  • EPS Growth
  • RCUS N/A
  • PLAB N/A
  • EPS
  • RCUS N/A
  • PLAB 1.77
  • Revenue
  • RCUS $262,000,000.00
  • PLAB $856,152,000.00
  • Revenue This Year
  • RCUS N/A
  • PLAB N/A
  • Revenue Next Year
  • RCUS N/A
  • PLAB $5.28
  • P/E Ratio
  • RCUS N/A
  • PLAB $13.13
  • Revenue Growth
  • RCUS 6.07
  • PLAB N/A
  • 52 Week Low
  • RCUS $6.50
  • PLAB $16.46
  • 52 Week High
  • RCUS $18.98
  • PLAB $31.60
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 68.53
  • PLAB 51.86
  • Support Level
  • RCUS $12.89
  • PLAB $22.54
  • Resistance Level
  • RCUS $16.12
  • PLAB $25.38
  • Average True Range (ATR)
  • RCUS 0.73
  • PLAB 0.82
  • MACD
  • RCUS 0.07
  • PLAB -0.06
  • Stochastic Oscillator
  • RCUS 44.17
  • PLAB 36.36

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: